Literature DB >> 31153772

Transmasculine Voice Modification: A Case Study.

Daniel P Buckley1, Kimberly L Dahl2, Gabriel J Cler2, Cara E Stepp3.   

Abstract

This case study measured the effects of manual laryngeal therapy on the fundamental frequency (fo), formant frequencies, estimated vocal tract length, and listener perception of masculinity of a 32-year-old transmasculine individual. The participant began testosterone therapy 1.5 years prior to the study. Two therapy approaches were administered sequentially in a single session: (1) passive circumlaryngeal massage and manual laryngeal reposturing, and (2) active laryngeal reposturing with voicing. Acoustic recordings were collected before and after each treatment and 3 days after the session. Speaking fo decreased from 124 Hz to 120 Hz after passive training, and to 108 Hz after active training. Estimated vocal tract length increased from 17.0 cm to 17.3 cm after passive training, and to 19.4 cm after active training. Eight listeners evaluated the masculinity of the participant's speech; his voice was rated as most masculine at the end of the training session. All measures returned to baseline at follow-up. Overall, both acoustic and perceptual changes were observed in one transmasculine individual who participated in manual laryngeal therapy, even after significant testosterone-induced voice changes had already occurred; however, changes were not maintained in the follow-up. This study adds to scant literature on effective approaches to and proposed outcome measures for voice masculinization in transmasculine individuals.
Copyright © 2019 The Voice Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Case study research; Circumlaryngeal massage; Laryngeal manual therapy; Transgender; Transmasculine; Voice therapy

Mesh:

Year:  2019        PMID: 31153772      PMCID: PMC6883145          DOI: 10.1016/j.jvoice.2019.05.003

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  31 in total

1.  Preliminary report on hormone receptors in the human vocal fold.

Authors:  S R Newman; J Butler; E H Hammond; S D Gray
Journal:  J Voice       Date:  2000-03       Impact factor: 2.009

2.  Impact of aberrant acoustic properties on the perception of sound quality in electrolarynx speech.

Authors:  Geoffrey S Meltzner; Robert E Hillman
Journal:  J Speech Lang Hear Res       Date:  2005-08       Impact factor: 2.297

3.  Articulatory changes in muscle tension dysphonia: evidence of vowel space expansion following manual circumlaryngeal therapy.

Authors:  Nelson Roy; Shawn L Nissen; Christopher Dromey; Shimon Sapir
Journal:  J Commun Disord       Date:  2008-11-01       Impact factor: 2.288

4.  Manual laryngeal reposturing as a primary approach for mutational falsetto.

Authors:  Nelson Roy; Elizabeth A Peterson; Jenny L Pierce; Marshall E Smith; Daniel R Houtz
Journal:  Laryngoscope       Date:  2016-04-23       Impact factor: 3.325

5.  Manual circumlaryngeal therapy for functional dysphonia: an evaluation of short- and long-term treatment outcomes.

Authors:  N Roy; D M Bless; D Heisey; C N Ford
Journal:  J Voice       Date:  1997-09       Impact factor: 2.009

6.  Male and female voice quality and its relationship to vowel formant frequencies.

Authors:  R O Coleman
Journal:  J Speech Hear Res       Date:  1971-09

7.  Voice, Articulation, and Prosody Contribute to Listener Perceptions of Speaker Gender: A Systematic Review and Meta-Analysis.

Authors:  Yeptain Leung; Jennifer Oates; Siew Pang Chan
Journal:  J Speech Lang Hear Res       Date:  2018-02-15       Impact factor: 2.297

8.  Assessment and treatment of musculoskeletal tension in hyperfunctional voice disorders.

Authors:  Nelson Roy
Journal:  Int J Speech Lang Pathol       Date:  2008       Impact factor: 2.484

9.  Longitudinal Case Study of Transgender Voice Changes Under Testosterone Hormone Therapy.

Authors:  Gabriel J Cler; Victoria S McKenna; Kimberly L Dahl; Cara E Stepp
Journal:  J Voice       Date:  2019-04-13       Impact factor: 2.009

10.  The CARE guidelines: consensus-based clinical case reporting guideline development.

Authors:  Joel J Gagnier; Gunver Kienle; Douglas G Altman; David Moher; Harold Sox; David Riley
Journal:  J Med Case Rep       Date:  2013-09-10
View more
  2 in total

1.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

2.  Testosterone therapy masculinizes speech and gender presentation in transgender men.

Authors:  Carolyn R Hodges-Simeon; Graham P O Grail; Graham Albert; Matti D Groll; Cara E Stepp; Justin M Carré; Steven A Arnocky
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.